CERVOMED INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.94 USD | -3.81% |
|
+1.34% | +148.23% |
| 05-29 | JonesTrading Starts CervoMed With Buy Rating, $70 Price Target | MT |
| 05-20 | CervoMed Names William Elder CFO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 156M | - | |||||
| 106B | ||||||
| 24.28B | - | |||||
| 21.96B | - | |||||
| 18.16B | ||||||
| 16.37B |
- Stock Market
- Equities
- CRVO Stock
- Charts CervoMed Inc.
- Sector Chart
